Global Peptide API CDMO Services Market Insights, Forecast to 2030

Global Peptide API CDMO Services Market Insights, Forecast to 2030



The global Peptide API CDMO Services market is projected to grow from US$ 2342.21 million in 2024 to US$ 5447.97 million by 2030, at a Compound Annual Growth Rate (CAGR) of 15.11% during the forecast period.

The US & Canada market for Peptide API CDMO Services is estimated to increase from $ 1219.66 million in 2024 to reach $ 2751.00 million by 2030, at a CAGR of 14.52% during the forecast period of 2024 through 2030.

The China market for Peptide API CDMO Services is estimated to increase from $ 205.66 million in 2024 to reach $ 638.65 million by 2030, at a CAGR of 20.79% during the forecast period of 2024 through 2030.

The Europe market for Peptide API CDMO Services is estimated to increase from $ 758.96 million in 2024 to reach $ 1655.34 million by 2030, at a CAGR of 13.88% during the forecast period of 2024 through 2030.

The global key companies of Peptide API CDMO Services include Bachem, PolyPeptide, CordenPharma, AmbioPharm, USV Peptides, Thermo Fisher, Bio Basic, JPT, Genscript, Chinese Peptide Company, etc. In 2023, the global top five players had a share approximately 54.92% in terms of revenue.

Report Includes

This report presents an overview of global market for Peptide API CDMO Services market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Peptide API CDMO Services, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Peptide API CDMO Services, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Peptide API CDMO Services revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Peptide API CDMO Services market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Peptide API CDMO Services revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Bachem, PolyPeptide, CordenPharma, AmbioPharm, USV Peptides, Thermo Fisher, Bio Basic, JPT, Genscript, Chinese Peptide Company, etc.

Market Segmentation

By Company

Bachem

PolyPeptide

CordenPharma

AmbioPharm

USV Peptides

Thermo Fisher

Bio Basic

JPT

Genscript

Chinese Peptide Company

ScinoPharm

ChengDu ShengNuo Biotec

CBL

Piramal Pharma

CPC Scientific

Segment by Type

GMP Services

Non-GMP Services

Segment by Application

Commercial

Scientific Research

Other

By Region

North America

United States

Canada

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Europe

Germany

France

U.K.

Italy

Russia

Rest of Europe

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Israel

GCC Countries

Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Revenue of Peptide API CDMO Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Peptide API CDMO Services companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.

Chapter 7: Europe by Type, by Application and by country, revenue for each segment.

Chapter 8: China by Type, and by Application, revenue for each segment.

Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.

Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.

Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Peptide API CDMO Services revenue, gross margin, and recent development, etc.

Chapter 12: Analyst's Viewpoints/Conclusions


1 Report Overview
1.1 Study Scope
1.2 Market Analysis By Type
1.2.1 Global Peptide Api Cdmo Services Market Size Growth Rate By Type: 2019 Vs 2023 Vs 2030
1.2.2 Gmp Services
1.2.3 Non-gmp Services
1.3 Market By Application
1.3.1 Global Peptide Api Cdmo Services Market Share By Application: 2019 Vs 2023 Vs 2030
1.3.2 Commercial
1.3.3 Scientific Research
1.4 Assumptions And Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Peptide Api Cdmo Services Market Perspective (2019-2030)
2.2 Global Peptide Api Cdmo Services Growth Trends By Region
2.2.1 Global Peptide Api Cdmo Services Market Size By Region: 2019 Vs 2023 Vs 2030
2.2.2 Peptide Api Cdmo Services Historic Market Size By Region (2019-2024)
2.2.3 Peptide Api Cdmo Services Forecasted Market Size By Region (2025-2030)
2.3 Peptide Api Cdmo Services Market Dynamics
2.3.1 Peptide Api Cdmo Services Industry Trends
2.3.2 Peptide Api Cdmo Services Market Drivers
2.3.3 Peptide Api Cdmo Services Market Challenges
2.3.4 Peptide Api Cdmo Services Market Restraints
3 Competition Landscape By Key Players
3.1 Global Revenue Peptide Api Cdmo Services By Players
3.1.1 Global Peptide Api Cdmo Services Revenue By Players (2019-2024)
3.1.2 Global Peptide Api Cdmo Services Revenue Market Share By Players (2019-2024)
3.2 Global Peptide Api Cdmo Services Market Share By Company Type (Tier 1, Tier 2, And Tier 3)
3.3 Global Key Players Of Peptide Api Cdmo Services, Ranking By Revenue, 2022 Vs 2023 Vs 2024
3.4 Global Peptide Api Cdmo Services Market Concentration Ratio
3.4.1 Global Peptide Api Cdmo Services Market Concentration Ratio (Cr5 And Hhi)
3.4.2 Global Top 3 And Top 5 Companies By Peptide Api Cdmo Services Revenue In 2023
3.5 Global Key Players Of Peptide Api Cdmo Services Head Office And Area Served
3.6 Global Key Players Of Peptide Api Cdmo Services, Product And Application
3.7 Global Key Players Of Peptide Api Cdmo Services Established Date
3.8 Mergers & Acquisitions, Expansion Plans
4 Peptide Api Cdmo Services Breakdown Data By Type
4.1 Global Peptide Api Cdmo Services Historic Market Size By Type (2019-2024)
4.2 Global Peptide Api Cdmo Services Forecasted Market Size By Type (2025-2030)
5 Peptide Api Cdmo Services Breakdown Data By Application
5.1 Global Peptide Api Cdmo Services Historic Market Size By Application (2019-2024)
5.2 Global Peptide Api Cdmo Services Forecasted Market Size By Application (2025-2030)
6 North America
6.1 North America Peptide Api Cdmo Services Market Size (2019-2030)
6.2 North America Peptide Api Cdmo Services Market Size By Type
6.2.1 North America Peptide Api Cdmo Services Market Size By Type (2019-2024)
6.2.2 North America Peptide Api Cdmo Services Market Size By Type (2025-2030)
6.2.3 North America Peptide Api Cdmo Services Market Share By Type (2019-2030)
6.3 North America Peptide Api Cdmo Services Market Size By Application
6.3.1 North America Peptide Api Cdmo Services Market Size By Application (2019-2024)
6.3.2 North America Peptide Api Cdmo Services Market Size By Application (2025-2030)
6.3.3 North America Peptide Api Cdmo Services Market Share By Application (2019-2030)
6.4 North America Peptide Api Cdmo Services Market Size By Country
6.4.1 North America Peptide Api Cdmo Services Market Size By Country: 2019 Vs 2023 Vs 2030
6.4.2 North America Peptide Api Cdmo Services Market Size By Country (2019-2024)
6.4.3 North America Peptide Api Cdmo Services Market Share By Country (2025-2030)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Peptide Api Cdmo Services Market Size (2019-2030)
7.2 Europe Peptide Api Cdmo Services Market Size By Type
7.2.1 Europe Peptide Api Cdmo Services Market Size By Type (2019-2024)
7.2.2 Europe Peptide Api Cdmo Services Market Size By Type (2025-2030)
7.2.3 Europe Peptide Api Cdmo Services Market Share By Type (2019-2030)
7.3 Europe Peptide Api Cdmo Services Market Size By Application
7.3.1 Europe Peptide Api Cdmo Services Market Size By Application (2019-2024)
7.3.2 Europe Peptide Api Cdmo Services Market Size By Application (2025-2030)
7.3.3 Europe Peptide Api Cdmo Services Market Share By Application (2019-2030)
7.4 Europe Peptide Api Cdmo Services Market Size By Country
7.4.1 Europe Peptide Api Cdmo Services Market Size By Country: 2019 Vs 2023 Vs 2030
7.4.2 Europe Peptide Api Cdmo Services Market Size By Country (2019-2024)
7.4.3 Europe Peptide Api Cdmo Services Market Size By Country (2025-2030)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Peptide Api Cdmo Services Market Size (2019-2030)
8.2 China Peptide Api Cdmo Services Market Size By Type
8.2.1 China Peptide Api Cdmo Services Market Size By Type (2019-2024)
8.2.2 China Peptide Api Cdmo Services Market Size By Type (2025-2030)
8.2.3 China Peptide Api Cdmo Services Market Share By Type (2019-2030)
8.3 China Peptide Api Cdmo Services Market Size By Application
8.3.1 China Peptide Api Cdmo Services Market Size By Application (2019-2024)
8.3.2 China Peptide Api Cdmo Services Market Size By Application (2025-2030)
8.3.3 China Peptide Api Cdmo Services Market Share By Application (2019-2030)
9 Asia (Excluding China)
9.1 Asia Peptide Api Cdmo Services Market Size (2019-2030)
9.2 Asia Peptide Api Cdmo Services Market Size By Type
9.2.1 Asia Peptide Api Cdmo Services Market Size By Type (2019-2024)
9.2.2 Asia Peptide Api Cdmo Services Market Size By Type (2025-2030)
9.2.3 Asia Peptide Api Cdmo Services Market Share By Type (2019-2030)
9.3 Asia Peptide Api Cdmo Services Market Size By Application
9.3.1 Asia Peptide Api Cdmo Services Market Size By Application (2019-2024)
9.3.2 Asia Peptide Api Cdmo Services Market Size By Application (2025-2030)
9.3.3 Asia Peptide Api Cdmo Services Market Share By Application (2019-2030)
9.4 Asia Peptide Api Cdmo Services Market Size By Region
9.4.1 Asia Peptide Api Cdmo Services Market Size By Region: 2019 Vs 2023 Vs 2030
9.4.2 Asia Peptide Api Cdmo Services Market Size By Region (2019-2024)
9.4.3 Asia Peptide Api Cdmo Services Market Size By Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 Southeast Asia
9.4.7 India
9.4.8 Australia
10 Middle East, Africa, And Latin America
10.1 Middle East, Africa, And Latin America Peptide Api Cdmo Services Market Size (2019-2030)
10.2 Middle East, Africa, And Latin America Peptide Api Cdmo Services Market Size By Type
10.2.1 Middle East, Africa, And Latin America Peptide Api Cdmo Services Market Size By Type (2019-2024)
10.2.2 Middle East, Africa, And Latin America Peptide Api Cdmo Services Market Size By Type (2025-2030)
10.2.3 Middle East, Africa, And Latin America Peptide Api Cdmo Services Market Share By Type (2019-2030)
10.3 Middle East, Africa, And Latin America Peptide Api Cdmo Services Market Size By Application
10.3.1 Middle East, Africa, And Latin America Peptide Api Cdmo Services Market Size By Application (2019-2024)
10.3.2 Middle East, Africa, And Latin America Peptide Api Cdmo Services Market Size By Application (2025-2030)
10.3.3 Middle East, Africa, And Latin America Peptide Api Cdmo Services Market Share By Application (2019-2030)
10.4 Middle East, Africa, And Latin America Peptide Api Cdmo Services Market Size By Country
10.4.1 Middle East, Africa, And Latin America Peptide Api Cdmo Services Market Size By Country: 2019 Vs 2023 Vs 2030
10.4.2 Middle East, Africa, And Latin America Peptide Api Cdmo Services Market Size By Country (2019-2024)
10.4.3 Middle East, Africa, And Latin America Peptide Api Cdmo Services Market Size By Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 Gcc Countries
11 Key Players Profiles
11.1 Bachem
11.1.1 Bachem Company Details
11.1.2 Bachem Business Overview
11.1.3 Bachem Peptide Api Cdmo Services Introduction
11.1.4 Bachem Revenue In Peptide Api Cdmo Services Business (2019-2024)
11.1.5 Bachem Recent Development
11.2 Polypeptide
11.2.1 Polypeptide Company Details
11.2.2 Polypeptide Business Overview
11.2.3 Polypeptide Peptide Api Cdmo Services Introduction
11.2.4 Polypeptide Revenue In Peptide Api Cdmo Services Business (2019-2024)
11.2.5 Polypeptide Recent Development
11.3 Cordenpharma
11.3.1 Cordenpharma Company Details
11.3.2 Cordenpharma Business Overview
11.3.3 Cordenpharma Peptide Api Cdmo Services Introduction
11.3.4 Cordenpharma Revenue In Peptide Api Cdmo Services Business (2019-2024)
11.3.5 Cordenpharma Recent Development
11.4 Ambiopharm
11.4.1 Ambiopharm Company Details
11.4.2 Ambiopharm Business Overview
11.4.3 Ambiopharm Peptide Api Cdmo Services Introduction
11.4.4 Ambiopharm Revenue In Peptide Api Cdmo Services Business (2019-2024)
11.4.5 Ambiopharm Recent Development
11.5 Usv Peptides
11.5.1 Usv Peptides Company Details
11.5.2 Usv Peptides Business Overview
11.5.3 Usv Peptides Peptide Api Cdmo Services Introduction
11.5.4 Usv Peptides Revenue In Peptide Api Cdmo Services Business (2019-2024)
11.6 Thermo Fisher
11.6.1 Thermo Fisher Company Details
11.6.2 Thermo Fisher Business Overview
11.6.3 Thermo Fisher Peptide Api Cdmo Services Introduction
11.6.4 Thermo Fisher Revenue In Peptide Api Cdmo Services Business (2019-2024)
11.7 Bio Basic
11.7.1 Bio Basic Company Details
11.7.2 Bio Basic Business Overview
11.7.3 Bio Basic Peptide Api Cdmo Services Introduction
11.7.4 Bio Basic Revenue In Peptide Api Cdmo Services Business (2019-2024)
11.8 Jpt
11.8.1 Jpt Company Details
11.8.2 Jpt Business Overview
11.8.3 Jpt Peptide Api Cdmo Services Introduction
11.8.4 Jpt Revenue In Peptide Api Cdmo Services Business (2019-2024)
11.9 Genscript
11.9.1 Genscript Company Details
11.9.2 Genscript Business Overview
11.9.3 Genscript Peptide Api Cdmo Services Introduction
11.9.4 Genscript Revenue In Peptide Api Cdmo Services Business (2019-2024)
11.9.5 Genscript Recent Development
11.10 Chinese Peptide Company
11.10.1 Chinese Peptide Company Company Details
11.10.2 Chinese Peptide Company Business Overview
11.10.3 Chinese Peptide Company Peptide Api Cdmo Services Introduction
11.10.4 Chinese Peptide Company Revenue In Peptide Api Cdmo Services Business (2019-2024)
11.11 Scinopharm
11.11.1 Scinopharm Company Details
11.11.2 Scinopharm Business Overview
11.11.3 Scinopharm Peptide Api Cdmo Services Introduction
11.11.4 Scinopharm Revenue In Peptide Api Cdmo Services Business (2019-2024)
11.11.5 Scinopharm Recent Development
11.12 Chengdu Shengnuo Biotec
11.12.1 Chengdu Shengnuo Biotec Company Details
11.12.2 Chengdu Shengnuo Biotec Business Overview
11.12.3 Chengdu Shengnuo Biotec Peptide Api Cdmo Services Introduction
11.12.4 Chengdu Shengnuo Biotec Revenue In Peptide Api Cdmo Services Business (2019-2024)
11.13 Cbl
11.13.1 Cbl Company Details
11.13.2 Cbl Business Overview
11.13.3 Cbl Peptide Api Cdmo Services Introduction
11.13.4 Cbl Revenue In Peptide Api Cdmo Services Business (2019-2024)
11.14 Piramal Pharma
11.14.1 Piramal Pharma Company Details
11.14.2 Piramal Pharma Business Overview
11.14.3 Piramal Pharma Peptide Api Cdmo Services Introduction
11.14.4 Piramal Pharma Revenue In Peptide Api Cdmo Services Business (2019-2024)
11.15 Cpc Scientific
11.15.1 Cpc Scientific Company Details
11.15.2 Cpc Scientific Business Overview
11.15.3 Cpc Scientific Peptide Api Cdmo Services Introduction
11.15.4 Cpc Scientific Revenue In Peptide Api Cdmo Services Business (2019-2024)
11.15.5 Cpc Scientific Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List Of Tables
Table 1. Global Peptide Api Cdmo Services Market Size Growth Rate By Type (Us$ Million): 2019 Vs 2023 Vs 2030
Table 2. Key Players Of Gmp Services
Table 3. Key Players Of Non-gmp Services
Table 4. Global Peptide Api Cdmo Services Market Size Growth By Application (Us$ Million): 2019 Vs 2023 Vs 2030
Table 5. Global Peptide Api Cdmo Services Market Size Growth Rate (Cagr) By Region (Us$ Million): 2019 Vs 2023 Vs 2030
Table 6. Global Peptide Api Cdmo Services Market Size By Region (2019-2024) & (Us$ Million)
Table 7. Global Peptide Api Cdmo Services Market Share By Region (2019-2024)
Table 8. Global Peptide Api Cdmo Services Forecasted Market Size By Region (2025-2030) & (Us$ Million)
Table 9. Global Peptide Api Cdmo Services Market Share By Region (2025-2030)
Table 10. Peptide Api Cdmo Services Market Trends
Table 11. Peptide Api Cdmo Services Market Drivers
Table 12. Peptide Api Cdmo Services Market Challenges
Table 13. Peptide Api Cdmo Services Market Restraints
Table 14. Global Peptide Api Cdmo Services Revenue By Players (2019-2024) & (Us$ Million)
Table 15. Global Peptide Api Cdmo Services Market Share By Players (2019-2024)
Table 16. Global Top Peptide Api Cdmo Services Players By Company Type (Tier 1, Tier 2, And Tier 3) & (Based On The Revenue In Peptide Api Cdmo Services As Of 2023)
Table 17. Global Peptide Api Cdmo Services Industry Ranking 2022 Vs 2023
Table 18. Global 5 Largest Players Market Share By Peptide Api Cdmo Services Revenue (Cr5 And Hhi) & (2019-2024)
Table 19. Global Key Players Of Peptide Api Cdmo Services, Headquarters And Area Served
Table 20. Global Key Players Of Peptide Api Cdmo Services, Product And Application

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings